Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2017 Mar 24;61(4):e00185-17. doi: 10.1128/AAC.00185-17

Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats

Nathaniel J Rhodes a,b, Walter C Prozialeck c, Thomas P Lodise d, Natarajan Venkatesan e,*, J Nicholas O'Donnell a, Gwendolyn Pais e, Cameron Cluff a, Peter C Lamar c, Michael N Neely f,g, Anil Gulati e, Marc H Scheetz a,b
PMCID: PMC5365701  PMID: 28341810

AUTHOR CORRECTION

Volume 60, no. 10, p. 5742–5751, 2016. A dilution factor correction was not used for our reported protein biomarkers. This correction factor for dilution is 2-fold for kidney injury molecule 1 (KIM-1), clusterin, and osteopontin and 500-fold for neutrophil gelatinase-associated lipocalin 2 and cystatin C. Thus, all reported point estimates for KIM-1, clusterin, and osteopontin should be doubled, and those for neutrophil gelatinase-associated lipocalin 2 and cystatin C should be multiplied by 500. The multiplicative differences do not affect any of the inferential statistics. All P values were isometric on recalculation. Therefore, the interpretation and conclusions of the manuscript remain the same.


Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES